Clarify Medical Core Technology Receives FDA Clearance
Life Sciences Jobs ... Source: BioSpace
<b>Ramaswamy</b> Launches Another New Biotech to Work on Phase III-Ready Drug From Merck & Co.
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-roivant-vivek-ramaswamy.jpg" NAME"Ramaswamy Launches Another New Biotech to Work on Phase III-Ready Drug From Merck & Co." ALT"Ramaswamy Launches Another New Biotech to Work on Phase III-Ready Drug From Merck…
Axovant Strengthens Executive Team With Key Management Appointments
Life Sciences Jobs ... Source: BioSpace
Novan Lays Off 20% of Workforce, Switches Up C-Suite
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"Novan Lays Off 20% of Workforce, Switches Up C-Suite" ALT"Novan Lays Off 20% of Workforce, Switches Up C-Suite"June 6, 2017By Alex Keown, BioSpace.com Breaking News StaffMORRISVILLE, N.C. Shares...…
Bay Area GRAIL's Billion Gamble on the Perfect Cancer Test
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-scientist5.jpg" NAME"Bay Area GRAIL's Billion Gamble on the Perfect Cancer Test" ALT"Bay Area GRAIL's Billion Gamble on the Perfect Cancer Test"June 6, 2017By Mark Terry, BioSpace.com Breaking News StaffWanted...…
Delcath Systems Announces Adjournment Of Annual Meeting Meeting Scheduled To Reconvene On June 16
NEW YORK, June 05, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH) (the Company) announced today that its 2017 Annual Meeting of Stockholders (the Annual Meeting), scheduled for June 5,…
Acorda Jumps as Parkinson???s Drug Performs Well in Late-Stage Study
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks5.jpg" NAME"Acorda Jumps as Parkinsons Drug Performs Well in Late-Stage Study" ALT"Acorda Jumps as Parkinsons Drug Performs Well in Late-Stage Study"June 6, 2017By Alex Keown, BioSpace.com Breaking News Staff<BR...…
FDA Cites Repeat Offender Over Sterility, GMPs
Ongoing quality issues at an Oklahoma outsourcing facility drew the ire of the FDA and a Form 483 for Qualgen—not a first for the company. Source: Drug Industry Daily
Janssen Sues Biosimilar Maker Celltrion Over its Remicade Manufacturing Patent
Janssen Biotech is suing Celltrion and Hospira in the latest of a series of lawsuits related to its blockbuster Remicade (infliximab) therapy. Source: Drug Industry Daily
- Go to the previous page
- 1
- …
- 429
- 430
- 431
- 432
- 433
- 434
- 435
- …
- 610
- Go to the next page